132 related articles for article (PubMed ID: 6788326)
21. Raynaud's phenomenon and systemic sclerosis.
Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin I2 fails to influence red cell deformability.
Slott JH; Hall K; Clark DA; Stuart MJ
Prostaglandins Leukot Med; 1982 Jan; 8(1):21-2. PubMed ID: 7043490
[No Abstract] [Full Text] [Related]
23. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
Hostein J; Bost R; Carpentier P; Franco A; Fournet J
Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
[TBL] [Abstract][Full Text] [Related]
24. Elevated homocysteine levels in patients with Raynaud's syndrome.
Danese S; Candelli M; Gasbarrini A
J Rheumatol; 2000 Aug; 27(8):2051. PubMed ID: 10955356
[No Abstract] [Full Text] [Related]
25. [Effect of prostaglandins E1, E2, D2, F2 alpha and I2 on the canine airways and pulmonary vascular bed (author's transl)].
Kitamura S; Ishihara Y; Sugiyama Y; Hsu LH
Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Sep; 17(9):560-6. PubMed ID: 393881
[No Abstract] [Full Text] [Related]
26. Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome.
Lucas GS; Simms MH; Caldwell NM; Alexander SJ; Stuart J
J Clin Pathol; 1984 Aug; 37(8):870-3. PubMed ID: 6540787
[TBL] [Abstract][Full Text] [Related]
27. Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels.
Mittag M; Beckheinrich P; Haustein UF
Acta Derm Venereol; 2001; 81(4):294-7. PubMed ID: 11720181
[TBL] [Abstract][Full Text] [Related]
28. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous microcirculation in systemic sclerosis and response to intra-arterial reserpine.
Nilsen KH; Jayson MI
Br Med J; 1980 Jun; 280(6229):1408-11. PubMed ID: 7427134
[TBL] [Abstract][Full Text] [Related]
30. [Raynaud's phenomena: diagnostic and treatment study].
Priollet P
Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
[TBL] [Abstract][Full Text] [Related]
31. Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon.
Biondi ML; Marasini B; Bianchi E; Agostoni A
Int J Cardiol; 1988 Jun; 19(3):335-9. PubMed ID: 3397197
[TBL] [Abstract][Full Text] [Related]
32. Effect of topical rosemary essential oil on Raynaud phenomenon in systemic sclerosis.
von Schoen-Angerer T; Deckers B; Henes J; Helmert E; Vagedes J
Complement Ther Med; 2018 Oct; 40():191-194. PubMed ID: 30219447
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.
Martin MF; Dowd PM; Ring EF; Cooke ED; Dieppe PA; Kirby JD
Ann Rheum Dis; 1981 Aug; 40(4):350-4. PubMed ID: 7259326
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandins E1, E2 and I2: evidence for three distinct actions in vascular smooth muscle.
Manku MS; Horrobin DF; Cunnane SC; Ally AI; Karmazyn M; Karmali RA; Morgan RO; Nicolaou KC; Barnette WE
Biochem Biophys Res Commun; 1978 Jul; 83(1):295-9. PubMed ID: 358978
[No Abstract] [Full Text] [Related]
35. An improved filtration rate for measuring red cell deformability.
Sowemimo-Coker SO; Kovacs IB; Turner P; Kirby JD
Biorheology Suppl; 1984; 1():249-53. PubMed ID: 6591983
[TBL] [Abstract][Full Text] [Related]
36. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
[TBL] [Abstract][Full Text] [Related]
37. Raynaud's phenomenon, histamine, and prostaglandins.
Horrobin DF; Jenkins K; Manku MS
Lancet; 1983 Sep; 2(8352):747-8. PubMed ID: 6136879
[No Abstract] [Full Text] [Related]
38. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
[TBL] [Abstract][Full Text] [Related]
39. The pharmacological effects of cicaprost, an oral prostacyclin analogue, in patients with Raynaud's syndrome secondary to systemic sclerosis--a preliminary study.
Lau CS; McLaren M; Saniabadi A; Scott N; Belch JJ
Clin Exp Rheumatol; 1991; 9(3):271-3. PubMed ID: 1879086
[TBL] [Abstract][Full Text] [Related]
40. [Sclerodermic acrosyndromes].
Carpentier PH
Rev Prat; 2002 Nov; 52(17):1891-5. PubMed ID: 12532865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
